A Comparison of Novel Serum Markers of Liver Health in Adolescents With Metabolic Dysfunction‐Associated Steatotic Liver Disease
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70817 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Neeharika Bade und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Gastroenterology, Hepatology, and Nutrition, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. Hauptthemen laut MEDLINE: Biomarkers, Liver, Fatty Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Paediatric Endocrine Society, University of Oklahoma Paediatric Metabolic Research Program.
Abstract (Originalsprache)
Several non‐invasive biomarkers for paediatric metabolic dysfunction‐associated steatotic liver disease (MASLD) have been reported, but no prior studies directly compared multiple protein or microRNA (miRNA) markers of liver health in adolescents with and without MASLD and determined which serum markers are associated with liver histopathological features. We measured 6 serum protein and 4 miRNA candidates in 3 groups of participants: 23 with obesity and biopsy‐proven MASLD, 24 controls with obesity (Ob) and 24 controls with normal weight (NW). The MASLD group had higher median values for cytokeratin 18 (CK‐18, 8.5 and 5.6‐fold higher than NW and Ob, respectively), CK‐18 fragments (2.6‐ and 2.6‐fold), collagen IV (0.9‐ and 0.6‐fold), miR‐122 (16.9‐ and 10.7‐fold) and miR‐192 (9.7‐ and 12.0‐fold). YKL‐40 and N‐terminal propeptide of type III procollagen were only higher in the MASLD group compared to the NW group. Serum AST, CK‐18, CK‐18 fragments, miR‐122 and miR‐192 were positively correlated with liver fibrosis stage. Area under the receiver operating curve for identifying MASLD for CK‐18 (0.962), miR‐192 (0.945) and miR‐122 (0.944) was higher than ALT (0.935). miR‐122 in serum and liver was inversely correlated in MASLD patients but neither was associated with putative mRNA targets AGPAT1 and DGAT1 . These results show that CK‐18, miR‐122 and miR‐192 are marginally better predictors of MASLD than ALT and correlated with fibrosis in this cohort, supporting further work to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Gastroenterology, Hepatology, and Nutrition, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
- Section of Diabetes and Endocrinology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
- Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
ORCID-Profile: Sirish K Palle
Förderung
- NIGMS NIH HHS
- Paediatric Endocrine Society
- University of Oklahoma Paediatric Metabolic Research Program
- Oklahoma Children's Health Foundation
- U.S. Department of Health and Human Services > National Institutes of Health
Zitieren
APA
Bade, N., Hellman, D. A., Matye, D. J., Jiang, S., Tryggestad, J. B., Yu, Z., Short, K. R., & Palle, S. K. (2025). A Comparison of Novel Serum Markers of Liver Health in Adolescents With Metabolic Dysfunction‐Associated Steatotic Liver Disease. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70817
Vancouver
Bade N, Hellman DA, Matye DJ, Jiang S, Tryggestad JB, Yu Z, et al. A Comparison of Novel Serum Markers of Liver Health in Adolescents With Metabolic Dysfunction‐Associated Steatotic Liver Disease. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70817
BibTeX
@article{Bade2025,
author = {Bade, Neeharika and Hellman, Diana A and Matye, David J and Jiang, Shaoning and Tryggestad, Jeanie B and Yu, Zhongxin and Short, Kevin R and Palle, Sirish K},
title = {A Comparison of Novel Serum Markers of Liver Health in Adolescents With Metabolic Dysfunction‐Associated Steatotic Liver Disease},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70817}
}
EUVIMED